JPS62187485A - ２４，２５−エポキシコレステロ−ル類の製造法 - Google Patents

２４，２５−エポキシコレステロ−ル類の製造法

Info

Publication number
JPS62187485A
JPS62187485A JP61028013A JP2801386A JPS62187485A JP S62187485 A JPS62187485 A JP S62187485A JP 61028013 A JP61028013 A JP 61028013A JP 2801386 A JP2801386 A JP 2801386A JP S62187485 A JPS62187485 A JP S62187485A
Authority
JP
Japan
Prior art keywords
group
formula
cholesterol
represented
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61028013A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0364510B2 (enExample
Inventor
Junichi Oshida
押田　淳一
Kenji Ishimaru
石丸　健二
Hideki Tsuruta
英樹 鶴田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP61028013A priority Critical patent/JPS62187485A/ja
Publication of JPS62187485A publication Critical patent/JPS62187485A/ja
Publication of JPH0364510B2 publication Critical patent/JPH0364510B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Steroid Compounds (AREA)
JP61028013A 1986-02-13 1986-02-13 ２４，２５−エポキシコレステロ−ル類の製造法 Granted JPS62187485A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61028013A JPS62187485A (ja) 1986-02-13 1986-02-13 ２４，２５−エポキシコレステロ−ル類の製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61028013A JPS62187485A (ja) 1986-02-13 1986-02-13 ２４，２５−エポキシコレステロ−ル類の製造法

Publications (2)

Publication Number Publication Date
JPS62187485A true JPS62187485A (ja) 1987-08-15
JPH0364510B2 JPH0364510B2 (enExample) 1991-10-07

Family

ID=12236888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61028013A Granted JPS62187485A (ja) 1986-02-13 1986-02-13 ２４，２５−エポキシコレステロ−ル類の製造法

Country Status (1)

Country Link
JP (1) JPS62187485A (enExample)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018519329A (ja) * 2015-07-06 2018-07-19 セージ セラピューティクス， インコーポレイテッド オキシステロールおよびそれらの使用の方法
US11104701B2 (en) 2013-03-13 2021-08-31 Sage Therapeutics, Inc. Neuroactive steroids and methods of use thereof
US11111266B2 (en) 2016-10-18 2021-09-07 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11117924B2 (en) 2015-07-06 2021-09-14 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11149056B2 (en) 2016-09-30 2021-10-19 Sage Therapeutics, Inc. C7 substituted oxysterols and methods of use thereof
US11149054B2 (en) 2016-10-18 2021-10-19 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11279730B2 (en) 2016-07-07 2022-03-22 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11407782B2 (en) 2016-05-06 2022-08-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11884697B2 (en) 2016-04-01 2024-01-30 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US12129276B2 (en) 2014-06-18 2024-10-29 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US12129275B2 (en) 2011-09-08 2024-10-29 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US12268697B2 (en) 2015-07-06 2025-04-08 Sage Therapeutics, Inc. Oxysterols and methods of use thereof

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12129275B2 (en) 2011-09-08 2024-10-29 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US11905309B2 (en) 2013-03-13 2024-02-20 Sage Therapeutics, Inc. Neuroactive steroids and methods of use thereof
US11104701B2 (en) 2013-03-13 2021-08-31 Sage Therapeutics, Inc. Neuroactive steroids and methods of use thereof
US12129276B2 (en) 2014-06-18 2024-10-29 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11732000B2 (en) 2015-07-06 2023-08-22 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US12268697B2 (en) 2015-07-06 2025-04-08 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
JP2018519329A (ja) * 2015-07-06 2018-07-19 セージ セラピューティクス， インコーポレイテッド オキシステロールおよびそれらの使用の方法
US11117924B2 (en) 2015-07-06 2021-09-14 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
JP2021063118A (ja) * 2015-07-06 2021-04-22 セージ セラピューティクス， インコーポレイテッド オキシステロールおよびそれらの使用の方法
US12448409B2 (en) 2016-04-01 2025-10-21 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11884697B2 (en) 2016-04-01 2024-01-30 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11407782B2 (en) 2016-05-06 2022-08-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11878995B2 (en) 2016-05-06 2024-01-23 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11279730B2 (en) 2016-07-07 2022-03-22 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11149056B2 (en) 2016-09-30 2021-10-19 Sage Therapeutics, Inc. C7 substituted oxysterols and methods of use thereof
US11926646B2 (en) 2016-09-30 2024-03-12 Sage Therapeutics, Inc. C7 substituted oxysterols and methods of use thereof
US12331070B2 (en) 2016-09-30 2025-06-17 Sage Therapeutics, Inc. C7 substituted oxysterols and methods of use thereof
US11613556B2 (en) 2016-10-18 2023-03-28 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US12180247B2 (en) 2016-10-18 2024-12-31 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11111266B2 (en) 2016-10-18 2021-09-07 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US11149054B2 (en) 2016-10-18 2021-10-19 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
US12540157B2 (en) 2016-10-18 2026-02-03 Sage Therapeutics, LLC Oxysterols and methods of use thereof

Also Published As

Publication number Publication date
JPH0364510B2 (enExample) 1991-10-07

Similar Documents

Publication Publication Date Title
JPS62187485A (ja) ２４，２５−エポキシコレステロ−ル類の製造法
CN103827075B (zh) 1-棕榈酰-3-乙酰基甘油的制备方法及使用其制备1-棕榈酰-2-亚油酰基-3-乙酰基甘油的方法
JP5646706B2 (ja) Ｃ−グリコシド誘導体の製造方法
CN108341738B (zh) 用于制备艾日布林的方法及其中间体
CN111533752A (zh) 一种叔丁基-7-溴-5-氧杂-2-氮杂螺[3.4]辛烷-2-甲酸基酯的制备方法
JP2515568B2 (ja) 新規なチアゾリジン誘導体
SU1277897A3 (ru) Способ получени 1,1-диоксо-6-бром(или-6,6-дибром)пеницилланоилоксиметиловых эфиров 6-(2-азидо-2-фенилацетамидо)пенициллановой кислоты
KR100365020B1 (ko) 아르부틴 중간체의 제조방법
JP7575764B2 (ja) ジピロメテン－１－オン系化合物及びその製造方法
JP3829273B2 (ja) 光学活性なフラバノン及びクロマノン類の製造法
JPH023797B2 (enExample)
KR20160070457A (ko) 루비프로스톤의 제조방법 및 그를 위한 중간체
CN108947995B (zh) 一种多取代噁二嗪衍生物的制备方法
JP5265144B2 (ja) ３−ｏ−置換−カテキン類誘導体の新規製造方法
KR20220011502A (ko) 신규한 이노토디올의 제조방법
CN116789559B (zh) 一种曲霉明a及其类似物的合成方法
CN111039963B (zh) Wxfl10203614水溶性类似物及其合成方法
US3928334A (en) Process for the production of cefamandole
CN105801534B (zh) 一种制备利马前列腺素的关键中间体及其应用
JP2540047B2 (ja) カスタステロン誘導体
CN103965130B (zh) 一种帕立骨化醇中间体的制备方法
KR100503022B1 (ko) 심바스타틴의 신규 제조방법 및 그에 사용되는 합성 중간체
JPS6287599A (ja) エリスロマイシン類のオキシム誘導体の製造法
JP2023016443A (ja) １，４－ジアセトキシ－２－メチルナフタレンの製造法
JPH0637460B2 (ja) １α―ヒドロキシ―ビタミンＤ▲下３▼の製造方法

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees